| 1 | we | 217,736 |
| 2 | 'we | 5 |
| 3 | •to | 5 |
| 4 | objective-to | 4 |
| 5 | capp3 | 3 |
| 6 | fracture-assessment | 2 |
| 7 | mixed-ibs | 2 |
| 8 | msg-cs | 2 |
| 9 | pre084 | 2 |
| 10 | respectively-were | 2 |
| 11 | strength-group | 2 |
| 12 | twelve-month-olds | 2 |
| 13 | ~bullet~to | 2 |
| 14 | *we | 1 |
| 15 | -4. | 1 |
| 16 | 1-amino-3-silyloxybutadienes | 1 |
| 17 | 17-month-olds | 1 |
| 18 | 1=artifact | 1 |
| 19 | 2-pyrimidinylcarbenes | 1 |
| 20 | 2007.authors | 1 |
| 21 | 2011-we | 1 |
| 22 | 2012-the | 1 |
| 23 | 2015-to | 1 |
| 24 | 2=artifact | 1 |
| 25 | 2d-electrophoresis | 1 |
| 26 | 3,6-dichlorocarbazole | 1 |
| 27 | 7,349 | 1 |
| 28 | 7785 | 1 |
| 29 | aimsto | 1 |
| 30 | aimto | 1 |
| 31 | anhl0131 | 1 |
| 32 | anti-angiogenics | 1 |
| 33 | antiandrogenics | 1 |
| 34 | auras-af | 1 |
| 35 | bis-values | 1 |
| 36 | bitemarks | 1 |
| 37 | blindness-method | 1 |
| 38 | body-temperatures | 1 |
| 39 | braconids | 1 |
| 40 | butyrates | 1 |
| 41 | cbcl/6-18 | 1 |
| 42 | cdc-atlanta | 1 |
| 43 | clopidogrel-treatment | 1 |
| 44 | co-outcomes | 1 |
| 45 | cortocosteroids | 1 |
| 46 | crozier | 1 |
| 47 | cuppers | 1 |
| 48 | cystationine | 1 |
| 49 | dermolab® | 1 |
| 50 | describle | 1 |
| 51 | dosing/week | 1 |
| 52 | emg/eeg | 1 |
| 53 | ensure-af | 1 |
| 54 | er… | 1 |
| 55 | fascially | 1 |
| 56 | feminists | 1 |
| 57 | fhhs | 1 |
| 58 | finder2 | 1 |
| 59 | fourier-transformed-infrared-spectroscopy | 1 |
| 60 | fourteen-trials | 1 |
| 61 | froscher | 1 |
| 62 | furanoids | 1 |
| 63 | gbsg-6 | 1 |
| 64 | geotherapeutics | 1 |
| 65 | glow6 | 1 |
| 66 | glycobiologists | 1 |
| 67 | hiv+women | 1 |
| 68 | home-arm | 1 |
| 69 | immunocompetency | 1 |
| 70 | incretino-mimetics | 1 |
| 71 | information-plus-bcts | 1 |
| 72 | iowans | 1 |
| 73 | iquad | 1 |
| 74 | isto | 1 |
| 75 | kroger | 1 |
| 76 | kt/w | 1 |
| 77 | l-dops+car | 1 |
| 78 | lge+patients | 1 |
| 79 | ma.27b | 1 |
| 80 | macroperforations | 1 |
| 81 | marci | 1 |
| 82 | mayeux | 1 |
| 83 | measurements/samples | 1 |
| 84 | mefloquine-currently | 1 |
| 85 | melancholics | 1 |
| 86 | metastudies | 1 |
| 87 | micro-models | 1 |
| 88 | microcalorimetrically | 1 |
| 89 | mini-clips | 1 |
| 90 | n-dimethyl-3-phenyl-3-pyridin-2-yl-propan-1-amine | 1 |
| 91 | n-diols | 1 |
| 92 | neoreactivities | 1 |
| 93 | non-inserters | 1 |
| 94 | nonheterosexually | 1 |
| 95 | normal/not | 1 |
| 96 | ntpdases1-3 | 1 |
| 97 | open-label-trial | 1 |
| 98 | outcomes•resource | 1 |
| 99 | p-th-bsos | 1 |
| 100 | parents/girls | 1 |
| 101 | peyote | 1 |
| 102 | phospho-upf1 | 1 |
| 103 | phytocompositions | 1 |
| 104 | piezoelectrics | 1 |
| 105 | postalwe | 1 |
| 106 | postquestionnaires | 1 |
| 107 | pre/posttesting | 1 |
| 108 | prenatal-rus | 1 |
| 109 | presentationwe | 1 |
| 110 | promo-intervention | 1 |
| 111 | propanidide | 1 |
| 112 | qus-insight | 1 |
| 113 | r-soxs | 1 |
| 114 | sb20350 | 1 |
| 115 | se-women | 1 |
| 116 | support/encouragement | 1 |
| 117 | supragingivally | 1 |
| 118 | switch-2-activity | 1 |
| 119 | toxilab | 1 |
| 120 | tresults | 1 |
| 121 | tsecs | 1 |
| 122 | uk-heart | 1 |
| 123 | vegetty | 1 |
| 124 | video-games | 1 |
| 125 | vinylpyridines | 1 |
| 126 | weight-changes | 1 |
| 127 | which-although | 1 |
| 128 | wwas | 1 |
| 129 | young-hunt | 1 |
| 130 | yt1 | 1 |
| 131 | zoffmann | 1 |
| 132 | ìwe | 1 |
| 133 | •we | 1 |
| 134 | ∆timp-4 | 1 |
| 1 | 'we | 5 |
| 2 | *we | 1 |
| 3 | -4. | 1 |
| 4 | 1-amino-3-silyloxybutadienes | 1 |
| 5 | 17-month-olds | 1 |
| 6 | 1=artifact | 1 |
| 7 | 2-pyrimidinylcarbenes | 1 |
| 8 | 2007.authors | 1 |
| 9 | 2011-we | 1 |
| 10 | 2012-the | 1 |
| 11 | 2015-to | 1 |
| 12 | 2=artifact | 1 |
| 13 | 2d-electrophoresis | 1 |
| 14 | 3,6-dichlorocarbazole | 1 |
| 15 | 7,349 | 1 |
| 16 | 7785 | 1 |
| 17 | aimsto | 1 |
| 18 | aimto | 1 |
| 19 | anhl0131 | 1 |
| 20 | anti-angiogenics | 1 |
| 21 | antiandrogenics | 1 |
| 22 | auras-af | 1 |
| 23 | bis-values | 1 |
| 24 | bitemarks | 1 |
| 25 | blindness-method | 1 |
| 26 | body-temperatures | 1 |
| 27 | braconids | 1 |
| 28 | butyrates | 1 |
| 29 | capp3 | 3 |
| 30 | cbcl/6-18 | 1 |
| 31 | cdc-atlanta | 1 |
| 32 | clopidogrel-treatment | 1 |
| 33 | co-outcomes | 1 |
| 34 | cortocosteroids | 1 |
| 35 | crozier | 1 |
| 36 | cuppers | 1 |
| 37 | cystationine | 1 |
| 38 | dermolab® | 1 |
| 39 | describle | 1 |
| 40 | dosing/week | 1 |
| 41 | emg/eeg | 1 |
| 42 | ensure-af | 1 |
| 43 | er… | 1 |
| 44 | fascially | 1 |
| 45 | feminists | 1 |
| 46 | fhhs | 1 |
| 47 | finder2 | 1 |
| 48 | fourier-transformed-infrared-spectroscopy | 1 |
| 49 | fourteen-trials | 1 |
| 50 | fracture-assessment | 2 |
| 51 | froscher | 1 |
| 52 | furanoids | 1 |
| 53 | gbsg-6 | 1 |
| 54 | geotherapeutics | 1 |
| 55 | glow6 | 1 |
| 56 | glycobiologists | 1 |
| 57 | hiv+women | 1 |
| 58 | home-arm | 1 |
| 59 | immunocompetency | 1 |
| 60 | incretino-mimetics | 1 |
| 61 | information-plus-bcts | 1 |
| 62 | iowans | 1 |
| 63 | iquad | 1 |
| 64 | isto | 1 |
| 65 | kroger | 1 |
| 66 | kt/w | 1 |
| 67 | l-dops+car | 1 |
| 68 | lge+patients | 1 |
| 69 | ma.27b | 1 |
| 70 | macroperforations | 1 |
| 71 | marci | 1 |
| 72 | mayeux | 1 |
| 73 | measurements/samples | 1 |
| 74 | mefloquine-currently | 1 |
| 75 | melancholics | 1 |
| 76 | metastudies | 1 |
| 77 | micro-models | 1 |
| 78 | microcalorimetrically | 1 |
| 79 | mini-clips | 1 |
| 80 | mixed-ibs | 2 |
| 81 | msg-cs | 2 |
| 82 | n-dimethyl-3-phenyl-3-pyridin-2-yl-propan-1-amine | 1 |
| 83 | n-diols | 1 |
| 84 | neoreactivities | 1 |
| 85 | non-inserters | 1 |
| 86 | nonheterosexually | 1 |
| 87 | normal/not | 1 |
| 88 | ntpdases1-3 | 1 |
| 89 | objective-to | 4 |
| 90 | open-label-trial | 1 |
| 91 | outcomes•resource | 1 |
| 92 | p-th-bsos | 1 |
| 93 | parents/girls | 1 |
| 94 | peyote | 1 |
| 95 | phospho-upf1 | 1 |
| 96 | phytocompositions | 1 |
| 97 | piezoelectrics | 1 |
| 98 | postalwe | 1 |
| 99 | postquestionnaires | 1 |
| 100 | pre/posttesting | 1 |
| 101 | pre084 | 2 |
| 102 | prenatal-rus | 1 |
| 103 | presentationwe | 1 |
| 104 | promo-intervention | 1 |
| 105 | propanidide | 1 |
| 106 | qus-insight | 1 |
| 107 | r-soxs | 1 |
| 108 | respectively-were | 2 |
| 109 | sb20350 | 1 |
| 110 | se-women | 1 |
| 111 | strength-group | 2 |
| 112 | support/encouragement | 1 |
| 113 | supragingivally | 1 |
| 114 | switch-2-activity | 1 |
| 115 | toxilab | 1 |
| 116 | tresults | 1 |
| 117 | tsecs | 1 |
| 118 | twelve-month-olds | 2 |
| 119 | uk-heart | 1 |
| 120 | vegetty | 1 |
| 121 | video-games | 1 |
| 122 | vinylpyridines | 1 |
| 123 | we | 217,736 |
| 124 | weight-changes | 1 |
| 125 | which-although | 1 |
| 126 | wwas | 1 |
| 127 | young-hunt | 1 |
| 128 | yt1 | 1 |
| 129 | zoffmann | 1 |
| 130 | ~bullet~to | 2 |
| 131 | ìwe | 1 |
| 132 | •to | 5 |
| 133 | •we | 1 |
| 134 | ∆timp-4 | 1 |
| 1 | -4. | 1 |
| 2 | sb20350 | 1 |
| 3 | anhl0131 | 1 |
| 4 | phospho-upf1 | 1 |
| 5 | yt1 | 1 |
| 6 | finder2 | 1 |
| 7 | ntpdases1-3 | 1 |
| 8 | capp3 | 3 |
| 9 | ∆timp-4 | 1 |
| 10 | pre084 | 2 |
| 11 | 7785 | 1 |
| 12 | gbsg-6 | 1 |
| 13 | glow6 | 1 |
| 14 | cbcl/6-18 | 1 |
| 15 | 7,349 | 1 |
| 16 | cdc-atlanta | 1 |
| 17 | ma.27b | 1 |
| 18 | toxilab | 1 |
| 19 | iquad | 1 |
| 20 | blindness-method | 1 |
| 21 | outcomes•resource | 1 |
| 22 | propanidide | 1 |
| 23 | 2012-the | 1 |
| 24 | describle | 1 |
| 25 | 3,6-dichlorocarbazole | 1 |
| 26 | n-dimethyl-3-phenyl-3-pyridin-2-yl-propan-1-amine | 1 |
| 27 | cystationine | 1 |
| 28 | respectively-were | 2 |
| 29 | peyote | 1 |
| 30 | we | 217,736 |
| 31 | 'we | 5 |
| 32 | *we | 1 |
| 33 | 2011-we | 1 |
| 34 | postalwe | 1 |
| 35 | presentationwe | 1 |
| 36 | •we | 1 |
| 37 | ìwe | 1 |
| 38 | ensure-af | 1 |
| 39 | auras-af | 1 |
| 40 | emg/eeg | 1 |
| 41 | pre/posttesting | 1 |
| 42 | which-although | 1 |
| 43 | marci | 1 |
| 44 | dosing/week | 1 |
| 45 | open-label-trial | 1 |
| 46 | home-arm | 1 |
| 47 | hiv+women | 1 |
| 48 | se-women | 1 |
| 49 | zoffmann | 1 |
| 50 | promo-intervention | 1 |
| 51 | 2015-to | 1 |
| 52 | objective-to | 4 |
| 53 | aimto | 1 |
| 54 | isto | 1 |
| 55 | aimsto | 1 |
| 56 | ~bullet~to | 2 |
| 57 | •to | 5 |
| 58 | strength-group | 2 |
| 59 | l-dops+car | 1 |
| 60 | kroger | 1 |
| 61 | froscher | 1 |
| 62 | crozier | 1 |
| 63 | wwas | 1 |
| 64 | mixed-ibs | 2 |
| 65 | msg-cs | 2 |
| 66 | tsecs | 1 |
| 67 | melancholics | 1 |
| 68 | anti-angiogenics | 1 |
| 69 | antiandrogenics | 1 |
| 70 | piezoelectrics | 1 |
| 71 | incretino-mimetics | 1 |
| 72 | geotherapeutics | 1 |
| 73 | braconids | 1 |
| 74 | furanoids | 1 |
| 75 | cortocosteroids | 1 |
| 76 | 17-month-olds | 1 |
| 77 | twelve-month-olds | 2 |
| 78 | weight-changes | 1 |
| 79 | metastudies | 1 |
| 80 | neoreactivities | 1 |
| 81 | measurements/samples | 1 |
| 82 | video-games | 1 |
| 83 | co-outcomes | 1 |
| 84 | 2-pyrimidinylcarbenes | 1 |
| 85 | 1-amino-3-silyloxybutadienes | 1 |
| 86 | vinylpyridines | 1 |
| 87 | postquestionnaires | 1 |
| 88 | body-temperatures | 1 |
| 89 | butyrates | 1 |
| 90 | bis-values | 1 |
| 91 | fhhs | 1 |
| 92 | 2d-electrophoresis | 1 |
| 93 | bitemarks | 1 |
| 94 | fourteen-trials | 1 |
| 95 | micro-models | 1 |
| 96 | n-diols | 1 |
| 97 | parents/girls | 1 |
| 98 | iowans | 1 |
| 99 | macroperforations | 1 |
| 100 | phytocompositions | 1 |
| 101 | p-th-bsos | 1 |
| 102 | mini-clips | 1 |
| 103 | cuppers | 1 |
| 104 | non-inserters | 1 |
| 105 | 2007.authors | 1 |
| 106 | information-plus-bcts | 1 |
| 107 | tresults | 1 |
| 108 | lge+patients | 1 |
| 109 | glycobiologists | 1 |
| 110 | feminists | 1 |
| 111 | prenatal-rus | 1 |
| 112 | r-soxs | 1 |
| 113 | 1=artifact | 1 |
| 114 | 2=artifact | 1 |
| 115 | qus-insight | 1 |
| 116 | support/encouragement | 1 |
| 117 | fracture-assessment | 2 |
| 118 | clopidogrel-treatment | 1 |
| 119 | young-hunt | 1 |
| 120 | normal/not | 1 |
| 121 | uk-heart | 1 |
| 122 | kt/w | 1 |
| 123 | mayeux | 1 |
| 124 | immunocompetency | 1 |
| 125 | microcalorimetrically | 1 |
| 126 | fascially | 1 |
| 127 | nonheterosexually | 1 |
| 128 | supragingivally | 1 |
| 129 | mefloquine-currently | 1 |
| 130 | fourier-transformed-infrared-spectroscopy | 1 |
| 131 | switch-2-activity | 1 |
| 132 | vegetty | 1 |
| 133 | er… | 1 |
| 134 | dermolab® | 1 |